[1] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|
[2] |
LEI Chao, QIAO Meng, CHEN Zijia, ZHANG Qiang, XIE Yanming, WANG Zhifei.
Revision of safety information in instructions of traditional Chinese patent medicines and simple preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1396-1400.
|
[3] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, YAN Suying.
Risk analysis and precautions related to storage conditions specified in package inserts of western medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 913-918.
|
[4] |
WEI Hongtao, SHEN Su, LI Dandan, LIAO Yin.
Pareto chart analysis of 705 problematic prescriptions in neurology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 900-903.
|
[5] |
ZHAO Jianbin, HUANG Yuling.
Risks and applications of parecoxib for injection based on drug instructions and judgment documents
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1250-1253.
|
[6] |
QIAO Weilin, LI Haiyan.
229 cases of adverse drug reactions caused by Keke tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 91-94.
|
[7] |
ZHANG Yongheng, HAN Chen, YANG Xiao, HAN Xiuqi, YUAN Hongchang, DENG Zhijian.
Analysis of 313 Instructions for Injectable Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 669-673.
|
[8] |
WANG Yuanzheng, LIU Bo, DENG Xia, GAO Chenyan, YANG Huan.
Considerations of Security Items in Vaccine Package Instructions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 334-337.
|
[9] |
ZHOU Sha, YANG Hongjun, JING Zhiwei, LI Geng.
Safety Information in Oral Chinese Patent Medicine Instructions for Big Brand Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 981-985.
|
[10] |
WENG Lihong, GAO Huan, HU Xue, ZHANG Wenrui.
Infusion Requirements on Labels of 39 Chinese Traditional Medicine Injections
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 437-440.
|
[11] |
LIU Min, HU Xue, LI Yanjiao, SONG Yanqing, WANG Xiangfeng.
Labeling of Instructions for Biopharmaceuticals for Intravenous Infusion
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(3): 165-168.
|
[12] |
LI Qing-fang, LIU Huan, ZHANG Dan-dan, YANG Yue, ZHANG Hui-xia, XIA Xu-dong, LIU Chao.
Analysis and Suggestions on Risk of Ribavirin in Children
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(2): 83-89.
|
[13] |
CUI Rong-na, Guan Yu, JIN Feng.
Analysis on Problems of Instructions of Chinese Traditional Patent Medicines Containing Toxic Ingredients
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(1): 42-44.
|